Ovation iX Iliac Stent Graft Iliac Limb (REF TV-IL141280-J)Recalls & reported problems
Endologix LLC · The TriVascular® Ovation Prime® Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft is an endovascular device delivered via a small diameter catheter to treat abdominal aortic aneurysms (AAAs). The stent graft is designed to reline the diseased vasculature, providing an endovascular blood conduit for isolating the aneurysm from the high pressure flow of blood, thereby reducing the risk of rupture. The stent graft is a modular configuration comprised of an aortic body section, iliac limbs, and iliac extensions as required. The TriVascular Ovation Prime Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft includes, an Aortic Body Stent Graft and delivery catheter, Iliac Limb Stent Grafts and delivery catheters, Iliac Extension Stent Grafts and delivery catheters, as required, a Fill Polymer Kit, and an Autoinjector. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI M701TVIL141280J1), received between Aug 22, 2016 and Dec 14, 2022 — classified as 4 injuries.
The most frequently reported specific device problem is “Inadequacy of Device Shape and/or Size” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Inadequacy of Device Shape and/or Size1
- Insufficient Device Problem Information1
- Obstruction of Flow1
- Occlusion Within Device1
Patient problems
- Failure of Implant3
- No Consequences Or Impact To Patient1
- Obstruction/Occlusion1
- Occlusion1
- Pain1
- Stenosis1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryDec 14, 2022Obstruction of Flow; Obstruction of Flow
THE PATIENT WAS IMPLANTED WITH THE ALTO STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). THE MAIN BODY AND OVATION IX ILIAC LIMBS WERE IMPLANTED IN EACH SIDE. AN ADDITIONAL OVATION IX ILIAC LIMB WAS IMPLANTED ON THE RIGHT SIDE. IT WAS REPORTED THAT SEVEN (7) HOURS AFTER THE IMPLANT PROCEDURE, THE PATIENT COMPLAINED OF RIGHT LOWER LIMB PAIN AT REST. A COMPUTED TOMOGRAPHY ANGIOGRAM (CTA) SHOWED THERE WAS RIGHT LIMB OCCLUSION (OVATION IX ILIAC LIMB). THE PHYSICIAN ELECTED TO PERFORM AN INTERVENTION AND THROMBUS WAS REMOVED FOLLOWED BY IMPLANT OF A MISAGO/TERUMO (NON-ENDOLOGIX) STENT TO SUCCESSFUL RESOLVE THE EVENT. TWO (2) DAYS AFTER THIS INTERVENTION THE PAIN WAS RESOLVED. THE PATIENT WAS DISCHARGED AT THE THIRD DAY POST PROCEDURE WITHOUT FURTHER COMPLICATIONS.
Patient problems: Failure of Implant; Obstruction/Occlusion; Pain
MAUDE report 15982917 ↗InjuryOct 29, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY IMPLANTED WITH THE OVATION IX ABDOMINAL STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY THREE (3) YEARS POST INITIAL IMPLANT, FOLLOWING A COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA) SCAN, A TYPE 1B ENDOLEAK OF THE RIGHT COMMON ILIAC AND A POSSIBLE TYPE 2 ENDOLEAK (NON-DEVICE-RELATED FAILURE) WERE IDENTIFIED. THE PATIENT IS SCHEDULED FOR RE-INTERVENTION. ADDITIONAL INFORMATION RECEIVED INDICATING THE SCHEDULED RE-INTERVENTION HAS BEEN CANCELLED.
Patient problems: Failure of Implant
MAUDE report 10755713 ↗InjurySep 29, 2017Occlusion Within Device; Occlusion Within Device
AN OVATION IX ILIAC LIMB STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE PATIENT RETURNED FOR A ROUTINE FOLLOW-UP WHERE PHYSICIAN OBSERVED ONE OF THE ILIAC LIMBS IS OCCLUDED. THE ANATOMY WAS NOTED TO BE EXTREMELY TORTUOUS. THE PATIENT IS ASYMPTOMATIC AND THERE ARE CURRENTLY NO PLANS FOR RE-INTERVENTION. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Failure of Implant; Occlusion; Stenosis
MAUDE report 6904627 ↗InjuryAug 22, 2016Inadequacy of Device Shape and/or Size; Adverse Event Without Identified Device or Use Problem; Inadequacy of Device Shape and/or Size; Adverse Event Without Identified Device or Use Problem
AN AFX ABDOMINAL STENT GRAFT WITH OVATION IX ILIAC LIMBS WERE IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. A LONGER THAN RECOMMENDED ILIAC LIMB STENT GRAFT WAS DEPLOYED INADVERTENTLY COVERING THE RIGHT INTERNAL ILIAC ARTERY. A BALLOON EXPANDABLE STENT WAS DEPLOYED IN THE RIGHT INTERNAL ILIAC ARTERY FOLLOWED BY THE PLACEMENT OF ANOTHER ILIAC LIMB STENT GRAFT TO MAINTAIN LUMINAL PATENCY. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED AND THE PATIENT WILL CONTINUE TO BE MONITORED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 5895335 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page